Cargando…
Experimental limitations of extracellular vesicle-based therapies for the treatment of myocardial infarction
Extracellular vesicles (EVs) are particles secreted by a vast variety of cells and are often recognised to mimic the properties of their parent cell, as such those derived from developmental sources hold promise for the treatment of various diseases including myocardial infarction (MI). Here we revi...
Autores principales: | Kennedy, Tahnee L, Russell, Angela J., Riley, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501308/ https://www.ncbi.nlm.nih.gov/pubmed/32822840 http://dx.doi.org/10.1016/j.tcm.2020.08.003 |
Ejemplares similares
-
Endothelium-derived extracellular vesicles promote splenic monocyte mobilization in myocardial infarction
por: Akbar, Naveed, et al.
Publicado: (2017) -
The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction
por: Crisóstomo, Verónica, et al.
Publicado: (2021) -
An extracellular vesicle epitope profile is associated with acute myocardial infarction
por: Burrello, Jacopo, et al.
Publicado: (2020) -
Regenerative potential of epicardium-derived extracellular vesicles mediated by conserved miRNA transfer
por: del Campo, Cristina Villa, et al.
Publicado: (2021) -
Differential clusterization of soluble and extracellular vesicle-associated cytokines in myocardial infarction
por: Lebedeva, Anna, et al.
Publicado: (2020)